Impact of Prior Therapy for Diabetic Macular Edema (DME) on Visual and Anatomic Outcomes Following Treatment with Intravitreal Aflibercept: Results from the Phase 3 VISTA-DME and VIVID-DME Studies

被引:0
|
作者
Quan Dong Nguyen [1 ]
机构
[1] Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Omaha, NE USA
关键词
499 diabetic retinopathy; 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials; 748 vascular endothelial growth factor;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
5055
引用
收藏
页数:2
相关论文
共 41 条
  • [21] Intravitreal Aflibercept for Diabetic Macular Edema 100-Week Results From the VISTA and VIVID Studies
    Brown, David M.
    Schmidt-Erfurth, Ursula
    Do, Diana V.
    Holz, Frank G.
    Boyer, David S.
    Midena, Edoardo
    Heier, Jeffrey S.
    Terasaki, Hiroko
    Kaiser, Peter K.
    Marcus, Dennis M.
    Nguyen, Quan D.
    Jaffe, Glenn J.
    Slakter, Jason S.
    Simader, Christian
    Soo, Yuhwen
    Schmelter, Thomas
    Yancopoulos, George D.
    Stahl, Neil
    Vitti, Robert
    Berliner, Alyson J.
    Zeitz, Oliver
    Metzig, Carola
    Korobelnik, Jean-Francois
    OPHTHALMOLOGY, 2015, 122 (10) : 2044 - 2052
  • [22] Intravitreal Aflibercept for Diabetic Macular Edema 148-Week Results from the VISTA and VIVID Studies
    Heier, Jeffrey S.
    Korobelnik, Jean-Franois
    Brown, David M.
    Schmidt-Erfurth, Ursula
    Do, Diana V.
    Midena, Edoardo
    Boyer, David S.
    Terasaki, Hiroko
    Kaiser, Peter K.
    Marcus, Dennis M.
    Nguyen, Quan D.
    Jaffe, Glenn J.
    Slakter, Jason S.
    Simader, Christian
    Soo, Yuhwen
    Schmelter, Thomas
    Vitti, Robert
    Berliner, Alyson J.
    Zeitz, Oliver
    Metzig, Carola
    Holz, Frank G.
    OPHTHALMOLOGY, 2016, 123 (11) : 2376 - 2385
  • [23] Impact of Systemic Dipeptidyl Peptidase-4(DPP-4) Inhibitors on Treatment Outcomes for Diabetic Macular Edema (DME) in the VISTA and VIVID trials
    Rahimy, Ehsan
    Baker, Keith
    Thompson, Desmond
    Saroj, Namrata
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [24] Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: ROTATED Trial 52 Week Results
    Taylor, Caitlen
    Frazier, Heather
    Rex, Priscila
    Marcus, William
    Starnes, Davis
    Walia, Harveen
    Singh, Harinderjit
    Lalane, Robert
    Marcus, Dennis M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies
    Wykoff, Charles Clifton
    Garweg, Justus G.
    Regillo, Carl
    Souied, Eric
    Wolf, Sebastian
    Dhoot, Dilsher
    Agostini, Hansjuergen T.
    Chang, Andrew
    Laude, Augustinus
    Kovacic, Lidija
    Wang, Lixin
    Wang, Ying
    Bouillaud, Emmanuel
    Brown, David M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [26] Primary Results from Two Phase 3 Trials of Faricimab for Diabetic Macular Edema (DME): YOSEMITE and RHINE
    Hu, Allen
    Willis, Jeffrey R.
    Haskova, Zdenka
    Silverman, David
    Ives, Jane
    Basu, Karen
    Lin, Hugh
    DIABETES, 2021, 70
  • [27] Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results
    Marcus, Dennis M.
    Frazier, Heather
    Rex, Priscila
    Marcus, William
    Starnes, Davis
    Walia, Harveen
    Singh, Harinderjit
    Lalane, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [28] Effect of Baseline Central Retinal Thickness (CRT) and Best Corrected Visual Acuity (BCVA) on Treatment Outcomes With Intravitreal Aflibercept Injection (IAI) or Macular Laser Photocoagulation in Diabetic Macular Edema (DME)
    Ogura, Yuichiro
    Feltgen, Nicolas
    Korobelnik, Jean-Francois
    Midena, Edoardo
    Katz, Todd A.
    Teukmantel, Claudia
    Metzig, Carola
    Zeitz, Oliver
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [29] Open-Label Phase 2 Study of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Edema (DME) in Vitrectomized Patients: Interim Results
    Gupta, S.
    Boyer, D. S.
    Faber, D.
    Patel, S. S.
    Liu, C. -C.
    Li, X. -Y.
    Whitcup, S. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [30] Different patterns of anti-VEGF loading phase for diabetic macular edema (DME) treatment: data analysis from the UK Aflibercept Users Group.
    Almuhtaseb, Hussein
    Stratton, Irene
    Scanlon, Peter Henry
    Lotery, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)